Half-year Report
4basebio PLC("4basebio", the "Company" or the “Group”) Half-year Reportfor the six months ended 30 June 2023 4basebio PLC (AIM: 4BB), Cambridge, UK, 21 September 2023 – 4basebio PLC, an innovation driven biotechnology company enabling and accelerating development of advanced therapy medicinal products (ATMPs) through its high performant synthetic DNA products and non-viral, thermostable nucleic acid delivery platform, announces its unaudited half-year results for the six months ended 30 June 2023. Operational Highlights (including post period end) · DNA and Hermes™